Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Indian Journal of Surgical Oncology

10-05-2024 | Original Article

Comparative Analysis of Clinicopathologic Characteristics and Outcomes of Urothelial Bladder Cancer Between Young and Older Adults—Experience from a Tertiary Care Center

Authors: Prashant Singh, Ankit Sachan, Brusabhanu Nayak, Rishi Nayyar, Rajeev Kumar, Amlesh Seth

Published in: Indian Journal of Surgical Oncology

Login to get access

Abstract

The evidence on bladder cancer in the young population remains fragmented due to lack of literature and conflicting results from the existing studies. We aim to elucidate such conflicting data and define the clinicopathologic characteristics, management trends, and outcomes of urothelial bladder carcinoma in young adults as compared to their older counterparts. This was a retrospective, single-center study involving patients with primary urothelial bladder cancer who underwent treatment at our center from March 2017 to March 2022. For analysis, patients were stratified into three subgroups based on age: group A, 18–40 years; group B, > 40 years; and group C, > 60 years. Group A with younger patients was compared with groups B and C. A total of 471 eligible patients (422 males and 49 females) were included in the study with a median age of 44 years. Group A had significantly lower recurrence and progression rates as compared to group B (31% vs 57.1%, p = 0.002 and 9.5% vs 19.2%, p = 0.04, respectively). Group A had significantly more recurrence-free survival (RFS) than group B (5-year-RFS = 68.03% vs 32.58%, p = 0.01). Similarly, group A also had lower recurrence (31% vs 62.6%, p < 0.001) and progression (9.5% vs 28.6%, p = 0.015) rates as compared to group C as well as better RFS (5-year-RFS = 68.03% vs 19.00%, p = 0.04) and progression-free survival (5-year-PFS = 83.1% vs 62.8%, p = 0.03) in comparison to group C. Age and tumor grade were found to be independent predictors of recurrence-free and progression-free survival. We concluded that high-grade disease is more common than low-grade disease both in younger and older patients. Younger patients fare better in terms of recurrence and progression when compared to their older counterparts.
Literature
1.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249CrossRefPubMed
2.
3.
Paner GP, Zehnder P, Amin AM, Husain AN, Desai MM (2011) Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management. Adv Anat Pathol 18(1):79–89CrossRefPubMed
4.
Na SW, Yu SH, Kim KH, Hwang EC, Jung SI, Kwon DD et al (2014) The prognosis of patients less than 40 years with bladder cancer. J Cancer Res Ther 10(3):710–714CrossRefPubMed
5.
Compérat E, Larré S, Roupret M, Neuzillet Y, Pignot G, Quintens H et al (2015) Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch 466(5):589–594CrossRefPubMed
6.
Caione P, Patruno G, Pagliarulo V, Bulotta AL, Salerno A, DiomediCamassei F et al (2017) Nonmuscular invasive urothelial carcinoma of the bladder in pediatric and young adult patients: age-related outcomes. Urology 99:215–220CrossRefPubMed
7.
Lara J, Brunson A, Keegan THM, Malogolowkin M, Pan CX, Yap S et al (2016) Determinants of survival for adolescents and young adults with urothelial bladder cancer: results from the California Cancer Registry. J Urol 196(5):1378–1382CrossRefPubMedPubMedCentral
8.
9.
Yossepowitch O, Dalbagni G (2002) Transitional cell carcinoma of the bladder in young adults: presentation, natural history and outcome. J Urol 168(1):61–66CrossRefPubMed
10.
Compérat EM, Burger M, Gontero P, Mostafid AH, Palou J, Rouprêt M et al (2019) Grading of urothelial carcinoma and the new “world health organisation classification of tumours of the urinary system and male genital organs 2016.” Eur Urol Focus 5(3):457–466CrossRefPubMed
11.
Magers MJ, Lopez-Beltran A, Montironi R, Williamson SR, Kaimakliotis HZ, Cheng L (2019) Staging of bladder cancer. Histopathology 74(1):112–134CrossRefPubMed
12.
13.
Telli O, Sarici H, Ozgur BC, Doluoglu OG, Sunay MM, Bozkurt S et al (2014) Urothelial cancer of bladder in young versus older adults: clinical and pathological characteristics and outcomes. Kaohsiung J Med Sci 30(9):466–470CrossRefPubMed
14.
Gunlusoy B, Ceylan Y, Degirmenci T, Kozacioglu Z, Yonguc T, Bozkurt H et al (2015) Urothelial bladder cancer in young adults: diagnosis, treatment and clinical behaviour. Can Urol Assoc J J Assoc Urol Can 9(9–10):E727-730CrossRef
15.
Stanton ML, Xiao L, Czerniak BA, Guo CC (2013) Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases. Arch Pathol Lab Med 137(10):1337–1341CrossRefPubMedPubMedCentral
16.
Islami F, Sauer AG, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ et al (2018) Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin 68(1):31–54CrossRefPubMed
17.
Toma TA (2022) Urothelial bladder cancer in young versus older adults: presentations, clinical characteristics, and outcomes. Zanco J Med Sci Zanco J Med Sci 26(1):29–37CrossRef
18.
Nomikos M, Pappas A, Kopaka ME, Tzoulakis S, Volonakis I, Stavrakakis G et al (2011) Urothelial carcinoma of the urinary bladder in young adults: presentation, clinical behavior and outcome. Adv Urol 2011:480738CrossRefPubMedPubMedCentral
19.
Fernandez-Gomez J, Madero R, Solsona E, Unda M, Martinez-Piñeiro L, Gonzalez M et al (2009) Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. J Urol 182(5):2195–2203CrossRefPubMed
20.
Sylvester RJ, Rodríguez O, Hernández V, Turturica D, Bauerová L, Bruins HM et al (2021) European association of urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel. Eur Urol 79(4):480–488CrossRefPubMed
21.
Ozbey I, Aksoy Y, Biçgi O, Polat O, Okyar G (1999) Transitional cell carcinoma of the bladder in patients under 40 years of age. Int Urol Nephrol 31(5):655–659CrossRefPubMed
22.
Tregunna R, Feneley M, Freeman A, Wood D (2019) Comparative outcomes of bladder cancer in patients under 40 years of age. J Endoluminal Endourol 2(4):e10–e19CrossRef
23.
Sen V, Bozkurt O, Demir O, Esen AA, Mungan U, Aslan G et al (2016) Clinical behavior of bladder urothelial carcinoma in young patients: a single center experience. Scientifica 2016:6792484CrossRefPubMedPubMedCentral
24.
Metadata
Title
Comparative Analysis of Clinicopathologic Characteristics and Outcomes of Urothelial Bladder Cancer Between Young and Older Adults—Experience from a Tertiary Care Center
Authors
Prashant Singh
Ankit Sachan
Brusabhanu Nayak
Rishi Nayyar
Rajeev Kumar
Amlesh Seth
Publication date
10-05-2024
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-024-01950-w